Skip to content

Patient Control Epidural Versus Conventional Epidural.

Patient Control Epidural Versus Conventional Epidural After Total Hip Replacement

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06721000
Enrollment
60
Registered
2024-12-06
Start date
2023-11-10
Completion date
2025-01-25
Last updated
2024-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amount of Analgesic Used, Degree of Motor Block, Length of Hospital Stay, Post Operative Pain, Acute, Sedation Score

Keywords

Patient control epidural analgesia, Conventional epidural

Brief summary

As one of the complications of THR is post operative pain, which usually requires epidural catheter insertion. We are comparing the effect of patient control epidural versus conventional epidural for patient's satisfaction.

Detailed description

More than 20 years of successful usage of epidural analgesia for post operative pain treatment include intermittent provider-administer bolus, patient control analgesia and continuous epidural infusion with or without patient control epidural analgesia. The main drawback of conventional epidural infusion is that it does not allow for individual variation in management of pain. As a result, patient control epidural analgesia has replaced it in recent years.3. It has been demonstrated that continuous epidural infusion with patient control epidural analgesia is highly effective at providing consistent analgesia, improving patient satisfaction, and reducing the workload of anesthesia provider but it is linked to higher local anesthetic consumption4 In patient undergoing THR, patient control epidural analgesia may be considered as an appropriate alternative for managing post operative pain.

Interventions

None listed

Sponsors

Liaquat National Hospital & Medical College
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age \>18 years. ASA 1-2 on pre anesthesia evaluation. Spontaneous breathing. Spo2 \>95% Informed consent for participation.

Exclusion criteria

A history of long-term opioid therapy (use of opioid analgesic at doses higher than codeine 120mg/day, hydrocodone 40mg/day, tramadol 200mg/day or oxycodone 40mg/day 0-4 days before surgery). Indication of revision surgery during immediate post operative care. Acute skin disease. Patients' refusal. ASA 3 and 4. Hypersensitivity to study drugs.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue score24 hoursPatient satisfaction will be assessed after 2hours, 12hours and 24hours after surgery according to patient's pain intensity. Score will be from 1-10, 10 means maximum satisfaction and 1 means minimal satisfaction.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026